Literature DB >> 30771083

Hypocalcemia and hypophosphatemia after treatment with zoledronic acid in a patient with AL amyloidosis.

Antonella Tufano1, Domenico Rendina2, Paolo Conca3, Beniamino Matani3, Giovanni Di Minno3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30771083     DOI： 10.1007/s11739-019-02048-w

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  5 in total

1.  New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes.

Authors:  Giovanni Palladini; Angela Dispenzieri; Morie A Gertz; Shaji Kumar; Ashutosh Wechalekar; Philip N Hawkins; Stefan Schönland; Ute Hegenbart; Raymond Comenzo; Efstathios Kastritis; Meletios A Dimopoulos; Arnaud Jaccard; Catherine Klersy; Giampaolo Merlini
Journal:  J Clin Oncol       Date:  2012-10-22       Impact factor: 44.544

Review 2.  Bisphosphonate induced hypocalcaemia - report of six cases and review of the literature.

Authors:  Veronika Kreutle; Claudine Blum; Christian Meier; Miriam Past; Beat Müller; Philipp Schütz; Katrin Borm
Journal:  Swiss Med Wkly       Date:  2014-06-25       Impact factor: 2.193

3.  A Case of Severe, Prolonged, Refractory Hypophosphatemia After Zoledronic Acid Administration.

Authors:  Sarah L Clark; Erin M Nystrom
Journal:  J Pharm Pract       Date:  2016-01-05

4.  Zoledronate Induced Hypocalcemia and Hypophosphatemia in Osteoporosis: A Cause of Concern.

Authors:  Upinder Kaur; Sankha Shubhra Chakrabarti; Indrajeet Singh Gambhir
Journal:  Curr Drug Saf       Date:  2016

Review 5.  Atypical immunoglobulin light chain amyloidosis: Spontaneous vertebral compression fracture, liver involvement, and bone marrow involvement report of 3 cases and review of the literature.

Authors:  Xia Wu; Jun Feng; Xinxin Cao; Lu Zhang; Daobin Zhou; Jian Li
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889
  5 in total
  1 in total

1.  Effects of Bisphosphonate Treatment on Circulating Lipid and Glucose Levels in Patients with Metabolic Bone Disorders.

Authors:  Gabriella Iannuzzo; Gianpaolo De Filippo; Daniela Merlotti; Veronica Abate; Alessio Buonaiuto; Marco Evangelista; Marco Gentile; Alfonso Giaquinto; Tommaso Picchioni; Matteo Nicola Dario Di Minno; Pasquale Strazzullo; Luigi Gennari; Domenico Rendina
Journal:  Calcif Tissue Int       Date:  2021-02-09       Impact factor: 4.333
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.